Fithian 13F annual report

Fithian is an investment fund managing more than $47.6 billion ran by Alexandra Ourusoff. There are currently 15 companies in Mrs. Ourusoff’s portfolio. The largest investments include Idexx Labs Inc and Bio-Techne Corp, together worth $16.4 billion.

$47.6 billion Assets Under Management (AUM)

As of 26th April 2023, Fithian’s top holding is 17,809 shares of Idexx Labs Inc currently worth over $8.91 billion and making up 18.7% of the portfolio value. In addition, the fund holds 101,020 shares of Bio-Techne Corp worth $7.49 billion, whose value fell 73.7% in the past six months. The third-largest holding is Alphabet Inc worth $7.95 billion and the next is Zoetis Inc worth $5.51 billion, with 33,082 shares owned.

Currently, Fithian's portfolio is worth at least $47.6 billion. The total portfolio value may be much higher due to cash assets that are not publicly disclosed such as fixed income, real estate, or cash equivalents.

Careers at Fithian

The Fithian office and employees reside in New York, New York. According to the last 13-F report filed with the SEC, Alexandra Ourusoff serves as the Chief Compliance Officer at Fithian.

Recent trades

In the most recent 13F filing, Fithian revealed that it had opened a new position in HDFC Bank and bought 19,280 shares worth $1.29 billion. This means they effectively own approximately 0.1% of the company. HDFC Bank makes up 20.9% of the fund's Finance sector allocation and has grown its share price by 24.4% in the past year.

The investment fund also strengthened its position in Idexx Labs Inc by buying 7,519 additional shares. This makes their stake in Idexx Labs Inc total 17,809 shares worth $8.91 billion.

One of the smaller hedge funds

The two most similar investment funds to Fithian are Axel Capital Management and Qualcomm Inc/de. They manage $47.4 billion and $48.2 billion respectively.

Alexandra Ourusoff investment strategy

Fithian’s portfolio is diversified across 5 sectors. Currently, their heaviest sector is Health Care — making up 36.1% of the total portfolio value. The fund focuses on investments in the United States as 73.3% of the portfolio companies are based in the United States.

The majority of the companies in the fund’s portfolio are large-cap stocks. Stocks with a size of more than $10 billion in market cap make up 73% of the total holdings value. On the other hand, small-cap stocks make up only 6.7% of the portfolio. The average market cap of the portfolio companies is close to $549 billion.

The complete list of Fithian trades based on 13F SEC filings

These positions were updated on May 3rd based on the fund’s latest 13F filing. Quickly find out what the most recently closed or increased positions are.

Security	Shares Owned	Value	Allocation
Idexx Labs Inc	73.07% 17,809	$8,905,925,000	18.69%
Bio-Techne Corp	135.05% 101,020	$7,494,674,000	15.73%
Alphabet Inc	135.43% 76,505	$7,952,194,000	16.69%
Zoetis Inc	138.89% 33,082	$5,506,168,000	11.56%
Trade Desk Inc	152.37% 71,316	$4,343,858,000	9.12%
Thermo Fisher Scientific Inc.	53.02% 7,322	$4,220,181,000	8.86%
Berkshire Hathaway Inc.	88.76% 13,168	$4,065,883,000	8.53%
Autodesk Inc.	121.00% 9,883	$2,057,245,000	4.32%
HDFC Bank Ltd.	Opened 19,280	$1,285,398,000	2.70%
Mastercard Incorporated	No change 1,540	$559,651,000	1.17%
Microsoft Corporation	0.09% 1,086	$313,218,000	0.66%
Apple Inc	No change 1,700	$280,330,000	0.59%
JPMorgan Chase & Co.	No change 1,882	$245,243,000	0.51%
Oreilly Automotive Inc	No change 252	$213,943,000	0.45%
Vanguard Index Fds	Opened 816	$203,442,000	0.43%
No transactions found
Showing first 500 out of 15 holdings